Product information and disease descriptionProduct description
Phase of product development
5 evidence topics · 5 sources
Investigational status
Investigational new drug application
Initiation of the Himalayas-1 Phase 3 trial
Himalayas-1 registry status and dates
| Registry field | Quoted record |
|---|---|
| Overall status | “Recruiting” |
| Study start (actual) | “2026-08-03” |
| Primary completion (estimated) | “2028-03” |
| Study completion (estimated) | “2030-09” |
License from Mirati Therapeutics
Expedited program designations
No evidence found.
Regulatory status
No evidence found.
Launch
No evidence found.